Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction
Heart Failure Outcomes With Volume-Guided Management
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.